Prescribing of amiodarone for atrial fibrillation and atrial flutter in Wales

Amiodarone has an important place in the treatment of severe cardiac rhythm disorders where other treatments either cannot be used or have failed; however, its use requires regular monitoring due to potential toxicities. Primary and secondary care clinicians have recognised that it would be beneficial to review all patients taking amiodarone in Wales to establish the need for ongoing treatment. The enclosed documentation has been developed to assist this process.

(September 2016)